AUTHOR=Liang Bo , He Xin , Gu Ning 

TITLE=Reassessing Revascularization Strategies in Coronary Artery Disease and Type 2 Diabetes Mellitus

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=8

YEAR=2021

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.738620

DOI=10.3389/fcvm.2021.738620

ISSN=2297-055X

ABSTRACT=<p>Percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is still controversial in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). Here, we aimed to evaluate the long-term follow-up events of PCI and CABG in these populations. Relevant randomized controlled trials were retrieved from PubMed, Embase, and the Cochrane databases. The pooled results were represented as risk ratios (RRs) with 95% confidence intervals (CIs) with STATA software. A total of six trials with 1,766 patients who received CABG and 2,262 patients who received PCI were included in our study. Patients in the CABG group were significantly associated with a lower all-cause mortality compared with those in the PCI group (RR = 0.74, 95% CI = 0.56–0.98, <italic>P</italic> = 0.037). Cardiac mortality, recurrent myocardial infarction, and repeat revascularization were also significantly lower in the CABG group (RR = 0.79, 95% CI = 0.40–1.53, <italic>P</italic> = 0.479; RR = 0.70, 95% CI = 0.32–1.56, <italic>P</italic> = 0.387; and RR = 0.36, 95% CI = 0.28–0.46, <italic>P</italic> &lt; 0.0001; respectively). However, compared with the PCI group, the cerebral vascular accident was higher in the CABG group (RR = 2.18, 95% CI = 1.43–3.33, <italic>P</italic> &lt; 0.0001). There was no publication bias in our study. CABG revascularization was associated with significantly lower long-term adverse clinical outcomes, except cerebral vascular accident, compared with PCI in patients with CAD and T2DM.</p><p><bold>Systematic Review Registration:</bold> PROSPERO, identifier: CRD42020216014.</p>